Metabolic rates may differ in people and depend upon gender, height, weight, age, muscle to fat ratios, and the current physical activity. The metabolism is divided into two types and can be divided into two categories catabolism which is the breakdown of food to obtain energy and anabolism which uses the energy produced by catabolic reactions to synthesize larger molecules from smaller ones like amino acids from proteins. catabolism and anabolism sets of reactions are critical to maintaining life.

According to the World Health Organization (WHO), over 650 million adults were obese, 41 million children under the age of 5 were obese. According to the Global Burden of Disease study, about 4.7 million people died prematurely as a result of obesity. Therefore the increasing prevalence of lifestyle diseases such as cardiovascular disease, obesity, diabetes, technological advancements, and healthcare expenditure are the key driving factors in the metabolic testing market.

Key Market Trends

Lifestyle Diseases Segment is Expected to Hold a Major Market Share in the Metabolic Testing Market

The lifestyle diseases segment holds a major market share and is expected to grow significantly over the forecast period. Lifestyle diseases like atherosclerosis, heart disease, obesity, and type 2 diabetes and diseases associated with smoking and alcohol consumption. Factors like lifestyle and dietary patterns have clear and distinguishable effects on cardiometabolic disease and other metabolic disorders.

According to the World Health Organization (WHO), at least 2.8 million individuals are dying each year as a result of being obese, and there are approximately 17 million deaths annually due to cardiovascular diseases. Hence, the rising prevalence of lifestyle diseases such as cardiovascular diseases, diabetes, and obesity are the key driving factors for the studied market.

North America is Expected to Hold a Significant Share in the Market and Expected to do Same in the Forecast Period

North America is expected to hold a major market share in the global metabolic testing market due to a rise in the prevalence of lifestyle diseases such as cardiovascular diseases, obesity, and type 2 diabetes in this region. According to the American Diabetes Association (ADA), in 2018, around 34.2 million Americans, or 10.5% of the population, had diabetes. Moreover, the rise in the adoption of advanced technologies in the metabolic testing market and the presence of well-established healthcare facilities is fueling the growth of the overall regional market to a large extent.

Competitive Landscape

The Metabolic Testing Market is moderately fragmented, competitive and consists of several market players. In terms of market share, few of the major players are currently dominating the market. Some of the companies which are currently dominating the market are MGC Diagnostics Corporation, COSMED Srl, CORTEX Biophysik GmbH, General Electric Company, KORR Medical Technologies, Inc, CareFusion Corporation, Geratherm Medical AG, OSI Systems, Inc, AEI Technologies, Inc, Parvo Medics.

Reasons to Purchase this report:

  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support